Skip to content

The effect of arginine on sexual function in men with diabetes

Effect of L.Argenine oral supplementation on sexual function in men with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015050322076N1
Enrollment
80
Registered
2015-08-04
Start date
2014-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sexual dysfunction. Lack or loss of sexual desire

Interventions

Intervention 1: The intervention group will take five grams of oral l-arginine in a 5 grams package for 28 days. Intervention 2: The control group will take five grams of oral Methyl Cellulose in 5
Treatment - Drugs
Placebo
The intervention group will take five grams of oral l-arginine in a 5 grams package for 28 days.
The control group will take five grams of oral Methyl Cellulose in 5 grams packages for 28 days

Sponsors

Yazd Shahid Sadoughi University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
25 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: being married; patients with mild to moderate erectile dysfunction (according to the score 15 to 25 obtained from the questionnaire of international index of erectile function (IIEF)); age between 25 to 55 years; a minimum of 5 years experience in diabetes. exclusion criteria: unstable cardiovascular status (angina and heart attack experience); cancer chemotherapy; those how taking reduced medications and secretion of androgen; surgery in the pelvic or prostate area; lack of personal satisfaction to log in to study; insulin users; consumers of opium and any apparent disorders of the genital system by endocrinologist assumption.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sexual function. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: IIEF Questionnaire.

Secondary

MeasureTime frame
Concentration of total testosterone. Timepoint: Before the intervention and after completion of the intervention. Method of measurement: Laboratory method Radio Immuno assay.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMosayeb Fallahi

Yazd Shahid Sadoughi University of Medical Sciences

mosayebfalahy@yahoo.com+98 35 3623 8505

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026